The PDK1-Rsk signaling pathway controls Langerhans cell proliferation and patterning by Zaru, R. et al.
of September 26, 2015.
This information is current as
PatterningLangerhans Cell Proliferation and 
Rsk Signaling Pathway Controls−The PDK1
Colin Watts
Alan R. Prescott, Diego Gomez-Nicola, André Hanauer and 
Rossana Zaru, Stephen P. Matthews, Alexander J. Edgar,
ol.1501520
http://www.jimmunol.org/content/early/2015/09/23/jimmun
 published online 23 September 2015J Immunol 
Material
Supplementary
0.DCSupplemental.html
http://www.jimmunol.org/content/suppl/2015/09/23/jimmunol.150152
Subscriptions
http://jimmunol.org/subscriptions
 is online at: The Journal of ImmunologyInformation about subscribing to 
Permissions
http://www.aai.org/ji/copyright.html
Submit copyright permission requests at: 
Email Alerts
http://jimmunol.org/cgi/alerts/etoc
Receive free email-alerts when new articles cite this article. Sign up at: 
Print ISSN: 0022-1767 Online ISSN: 1550-6606. 
Copyright © 2015 The Authors All rights reserved.
9650 Rockville Pike, Bethesda, MD 20814-3994.
The American Association of Immunologists, Inc.,
 is published twice each month byThe Journal of Immunology
 by guest on Septem
ber 26, 2015
http://w
w
w
.jimmunol.org/
D
ow
nloaded from
 
 by guest on Septem
ber 26, 2015
http://w
w
w
.jimmunol.org/
D
ow
nloaded from
 
The Journal of Immunology
The PDK1–Rsk Signaling Pathway Controls Langerhans Cell
Proliferation and Patterning
Rossana Zaru,*,1 Stephen P. Matthews,* Alexander J. Edgar,* Alan R. Prescott,*
Diego Gomez-Nicola,† Andre´ Hanauer,‡ and Colin Watts*
Langerhans cells (LC), the dendritic cells of the epidermis, are distributed in a distinctive regularly spaced array. In the mouse, the
LC array is established in the first few days of life from proliferating local precursors, but the regulating signaling pathways are
not fully understood. We found that mice lacking the kinase phosphoinositide-dependent kinase 1 selectively lack LC. Deletion of
the phosphoinositide-dependent kinase 1 target kinases, ribosomal S6 kinase 1 (Rsk1) and Rsk2, produced a striking perturbation
in the LC network: LC density was reduced 2-fold, but LC size was increased by the same magnitude. Reduced LC numbers in
Rsk1/22/2 mice was not due to accelerated emigration from the skin but rather to reduced proliferation at least in adults. Rsk1/2
were required for normal LC patterning in neonates, but not when LC were ablated in adults and replaced by bone marrow–
derived cells. Increased LC size was an intrinsic response to reduced LC numbers, reversible on LC emigration, and could be
observed in wild type epidermis where LC size also correlated inversely with LC density. Our results identify a key signaling
pathway needed to establish a normal LC network and suggest that LC might maintain epidermal surveillance by increasing their
“footprint” when their numbers are limited. The Journal of Immunology, 2015, 195: 000–000.
I
mmune surveillance in the skin is mediated by different
dendritic cell (DC) populations including Langerhans cells
(LC), which form a network in the epidermis (1, 2). They
differ from the other DC populations in that they originate from
the yolk sac and the fetal liver and colonize the epidermis just
before birth (3, 4). During the first week of life they differen-
tiate into LC and undergo a rapid but transient burst in pro-
liferation that establishes their unique network. In the adult, at
the steady-state, the homeostasis of the LC network is main-
tained through a balance of in situ proliferation of local pre-
cursors and a slow but constant migration to the skin draining
lymph nodes (2, 5–8). Only upon skin injury, such as in the case
of UV irradiation, are LC replaced first by monocytes, which
transiently repopulate the epidermis, and then by bone marrow
precursors, which provide long-term reconstitution (5, 9).
The mechanisms behind LC development have been the subject of
intense recent investigation. TGF-b1 produced by both keratinocytes
and LC has been shown to be essential to maintain the LC network
and prevents their spontaneous migration to lymph nodes (10–12).
IL-34 produced by keratinocytes is also required for the develop-
ment of LC (13, 14). Two transcriptions factors, Id2 and runx3,
acting downstream of TGF-b1 have been reported to be essential for
LC differentiation in the steady-state (15–17). More recently, a role
for the kinase complex mTORC1 and p14, a subunit of the LAM-
TOR complex, that can regulate mTOR function have been identi-
fied as important for the proliferation and survival of LC (18, 19), in
the case of p14, by maintaining functional TGF-b1 signaling (20).
Thus, although some of the factors governing the development and
maintenance of LC have been identified, our understanding of the
required intracellular signaling pathways is at an early stage.
The p90 kDa ribosomal S6 kinases (Rsks) are Ser/Thr kinases
of the AGC kinase family that require activation by both
phosphoinositide-dependent kinase 1 (PDK1) and Erk1/2 in most
cell types (21). In DCs, Rsks can also be activated by MK2/3
acting downstream of p38 MAPK (22, 23). PDK1 is required for
the development of T cells (24) and B cells (25) but is dis-
pensable for the development of macrophages and granulocytes
(25, 26). Downstream of PDK1, Rsks regulate several cellular
processes including cell proliferation, survival, transcription, trans-
lation, and metabolism (21). Because IL-34 is known to acti-
vate Erk1/2 (27), one of the upstream activators of Rsk, we
assessed the contribution of Rsks to LC biology taking advantage
of newly generated mice lacking multiple Rsk isoforms. In this
article, we show that the PDK1–Rsk pathway is critical for es-
tablishment and maintenance of a normal LC network in mice. In
addition, we present evidence that LC may respond to reduced
numbers with an increase in LC surface area or “footprint.”
Materials and Methods
Mice
Rsk1 and Rsk2 single-knockout (KO) mice were generated as described
by Yang et al. (28) and Laugel-Haushalter et al. (29) and maintained on
a Bl6/C57 background. Rsk1 and Rsk2 double-KO mice were generated
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by crossing Rsk1 and Rsk2 single-KO mice. Hematopoietic deletion
of PDK1 was achieved by crossing floxed PDK1 mice with Vav-Cre
transgenic mice as described by Venigalla et al. (25). Mice were used
between 6 wk and 6 mo of age and were bred and maintained under
specific pathogen-free conditions. Animal experimentation was ap-
proved by the University of Dundee Animal Ethics Committee and was
done under a U.K. Home Office Project License.
Immunofluorescence and cell-size measurement
Ear splits from adult mice or skin from the trunk of 1- or 5-d-old mice were
incubated in 0.5M ammonium thiocyanate for 20 min at 37˚C. Epidermis
was separated from the dermis, fixed for 25 min in 4% paraformaldehyde
in PBS, blocked with 1% BSA in PBS, and permeabilized with 0.3%
Triton X-100 in PBS for 5 min. Epidermal sheets were stained with
Alexa 488–labeled class II MHC Abs (M115/4 clone; Biolegend), FITC-
labeled CD45 Abs (eBioscience), or biotin-labeled Langerin Abs
(eBioscience) followed by Alexa 555–labeled streptavidin (Invitrogen)
and DAPI (Molecular Probes). For each mouse, 5–10 fields were chosen
at random and 0.9-mm thick sections were collected on a LSM700
confocal microscope (Zeiss) with a 403 objective. Maximum intensity
projections were made and class II MHC+ cells/mm2 were counted. Cell-
surface area and volume were measured using Volocity software (Perkin
Elmer). Automatic settings were used to find objects (Otsu’s method) in
each image. The offset was set at 265. Some images were analyzed
using SD of intensity .2.3. Objects ,200 or .5000 mm3 were excluded.
Objects were filtered by long axis ,100 mm. Surface area is defined as
the total area of triangles fitted to the surface voxels of the data set. Each
image was checked manually to remove cell doublets and hair.
In vitro LC migration
Ear splits were floated on RPMI 1640 medium supplemented with 10%
FCS, non-essential amino acids, Na pyruvate, kanamycin and beta-
mercaptoethanol (epidermis facing down) for 0 (control) or 72 h at 37˚C.
The epidermis was removed, fixed, and stained with anti–MHC class II
Abs as described earlier. Five to 10 fields were chosen, and 0.9-mm-thick
sections were collected on a LSM700 confocal microscope (Zeiss) with
a 403 objective, and number of LC/field was quantified.
Flow cytometry
Ear splits were incubated in 2.4 U/ml Dispase II (Roche) for 1 h 30 min at
37˚C. The epidermis was separated from the dermis and both tissues
were incubated in 2% FCS-RPMI 1640 with 2 mg/ml collagenase D and
100 mg/ml DNAse I (Roche) for 45 min at 37˚C. Skin draining lymph
nodes or spleen was digested in 2% FCS-RPMI 1640 with 2 mg/ml
collagenase D and 100 mg/ml DNAse I for 30 min at 37˚C. Epidermis,
dermis, and lymph node cell suspensions were stained on ice for 30 min
with A488-labeled anti-CD45, PE-labeled anti-CD40, PerCP-Cy5.5–la-
beled anti-CD86, allophycocyanin-labeled anti-EpCAM, e700-labeled
anti-CD11c, PE-labeled CD103 or FITC, and e700-labeled anti–MHC
class II (eBioscience) Abs. Spleen cell suspension was stained with
allophycocyanin-labeled anti-CD11c (BD Biosciences), FITC-labeled
anti-Siglec H, PerCP-Cy5.5–labeled anti-CD11b and e700-labeled anti-
CD8a Abs (eBioscience). Bone marrow cell suspension was stained
FITC-labeled anti-Siglec H and allophycocyanin-labeled anti-B220 Abs
(eBioscience). The analysis was performed on a BD Fortessa (BD
biosciences). For intracellular staining, cells were fixed with 2%
paraformaldehyde/PBS for 10 min at 37˚C, permeabilized with 90%
MeOH for 20 min on ice, and stained with A488-labeled anti-CD45, PE-
labeled anti–MHC class II, and anti–phospho-S6 Abs (Cell Signaling).
Cell-cycle analysis
Epidermal single-cell suspensions were incubated with 15 mg/ml Hoechst
33342 (Molecular Probes) in 2% FCS in PBS for 30 min at 37˚C. Cells
were stained with A488-labeled CD45 and PE-labeled MHC class II Abs
(eBioscience) on ice. TOPRO-3 (Molecular Probes) was used as a live/
dead exclusion marker. Fluorescence was analyzed by flow cytometry as
described earlier.
Bone marrow chimera and UV irradiation
Five- to 6-wk-old littermate or age-matched CD45.1 mice were irradiated
3 h apart with 12 Gy in total. One hour after the last irradiation, mice were
injected i.v. with 106 wild type (WT) or Rsk1/2-null bone marrow cells.
Three to 4 wk after irradiation, one ear was exposed to UV light as in
Merad et al. (5). Three to four weeks later, epidermis was removed, and LC
density and size were assessed as described earlier.
Brain immunohistochemistry
Brain sections were stained and analyzed as described by Go´mez-Nicola
et al. (30, 31).
Statistics
Unpaired t test and two-way ANOVA were used for the statistical
analysis of the data (Prism 6, GraphPad Software); *p = 0.01–0.05,
**p = 0.001–0.01, and ***p , 0.001.
Results
PDK1 is required for LC development in the epidermis
To investigate the role of PDK1 in LC homeostasis, we crossed
PDK1fl/fl mice with Vav-Cre+ve mice to delete PDK1 in the he-
matopoietic compartment (25). Epidermal sheets were stained
with class II MHC Abs, a marker of LC. Remarkably, the epi-
dermis from PDK1fl/fl/Vav-Cre+ve mice completely lacked LC
(Fig. 1A). This was not simply due to a loss of class II MHC
expression because no LC were detected using other markers
such as CD45, Langerin, CD11c, and high levels of EpCAM
(Fig. 1B and data not shown). Moreover, when we assessed the
presence of LC by flow cytometry using the hematopoietic
marker CD45, we found that dendritic epidermal T cells (DETC)
were also absent (Fig. 1C), supporting previous data showing
that PDK1 is essential for T cell development (24, 32). The
absence of LC was not the result of an enhanced spontaneous
migration to the dermis because no CD45+EpCAM+ class II
MHC+ LC were found in that compartment (Fig. 1D). Whereas
resident dermal CD103+ DCs were absent in PDK1fl/fl/Vav-
Cre+ve mice, dermal CD11b+ DCs were present (Fig. 1D),
indicating that the loss of PDK1 differentially affected the
generation of dermal DCs. As shown previously by Venigalla
et al. (25), the distribution of DC subsets in the bone marrow, the
spleen, and the lymph nodes of PDK1fl/fl/Vav-Cre+ve mice was
similar to WT mice (Fig. 1E, 1F, and data not shown). Thus,
PDK1 is required for the development of LC and CD103+ der-
mal DCs but is dispensable for DC development in lymphoid
organs.
Rsk1 and Rsk2 regulate LC size and density
The earlier results prompted us to investigate which PDK1
downstream effectors were required for LC development. PDK1
activates several downstream Ser/Thr kinases of the AGC family
including Rsk, PKB, and S6K (33). Because Rsk isoforms con-
trol several biological processes including gene transcription,
proliferation, and survival, we asked whether loss of Rsk could
impair LC development downstream of PDK1. This was chal-
lenging because four Rsk isoforms exist, of which three (Rsk1,
Rsk2, and Rsk3) are expressed in LC according to the Immu-
nological Genome Project database (http://www.immgen.org/
index_content.html) (34). Single Rsk isoform-deficient mice were
viable and had no obvious morphological defects except for
Rsk22/2 mice, which, as previously reported, were smaller (29).
Moreover, LC were present in normal numbers in mice lacking
a single Rsk isoform. Mice lacking both Rsk1 and Rsk2 (hereafter
Rsk1/2-null mice) were viable and fertile, but the litters were
small and few doubly deficient mice were obtained. Similar to
Rsk22/2 mice, their size was reduced compared with littermate
controls (Fig. 2A).
When the epidermis of Rsk1/2-null mice was examined, we
found that LC were present with normal dendritic morphology
and homogenous distribution (Fig. 2B). However, conversely to
the epidermis of Rsk12/2 or Rsk22/2 mice, their density was
half that of WT (Fig. 2C, Supplemental Fig. 1A). Remarkably,
although fewer, LC were substantially increased in size in Rsk1/
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2-null mice (Fig. 2B, 2C). To investigate whether deleting Rsk3
would have an additional effect, we obtained rare mice lacking
Rsk1, Rsk2, and Rsk3. They were viable and had a similar LC
phenotype as Rsk1/2-null mice (data not shown), indicating that
the regulation of the size and density of LC is mainly regulated
by Rsk1 and Rsk2. Rsk1/2-null mice were used for all further
experiments.
Rsk1/2 deletion selectively affected LC because other DC
subsets including plasmacytoid DCs, CD8+ DCs, and CD82 DCs
were present in similar numbers in the spleen and lymph nodes
of Rsk1/2-null mice and WT controls (Fig. 2E, 2F). Moreover,
microglia, which like LC are also long lived and self-renew in
situ by proliferation (35, 36), were present in the hippocampus
in normal numbers and had a similar size in WT and Rsk1/2-null
mice (Fig. 2D and data not shown). There was a modest but
significant increase in the number of iba1+ microglial cells in
the cortex of the Rsk1/2-null mice (Fig. 2D). Taken together,
these results reveal a selective requirement for Rsk1/2 for nor-
mal LC development.
Rsk1 and Rsk2 control LC proliferation in newborn and adult
mice
Next, we investigated the cause of the reduced LC density. LC
homeostasis is maintained by in situ proliferation and by mi-
gration to the skin draining lymph nodes (2, 5, 7). We asked
whether the migration rate of LC was accelerated in Rsk1/2-null
mice, which might explain their reduced number. To measure LC
migration, we incubated ear splits in medium for 0 (control) or
3 d and quantified by microscopy LC remaining in the epidermis.
As shown in Fig. 3A, the absence of Rsk1/2 did not affect LC
migration rate. Fewer LC were found in the dermis of Rsk1/2-
null mice (Fig. 3B) and apparently lymph nodes (Fig. 3C), al-
though in the latter case this did not reach significance, most
likely because of low and variable LC numbers. Nonetheless,
lower numbers in dermis and draining nodes were expected
given the reduced numbers in the epidermis.
Because the reduced LC density was not due to an increase
in migration, we next investigated whether their capacity to
FIGURE 1. LC are absent in PDK1fl/fl Vav Cre+ve mice. (A and B) Immunofluorescence of PDK1+/+ Vav Cre+ve (WT) (A and B) or PDK1fl/fl Vav Cre+ve
(PDK1 KO) (A and B) epidermal sheets stained with DAPI (blue), MHC class II (green) (A), CD45 (green) (B), or Langerin (red) Abs (B). Scale bar, 50 mm.
(C–F) Flow-cytometry analysis of DC populations in epidermis (C), dermis (D), bone marrow (E), and spleen (F) of PDK1+/+ Vav Cre+ve (WT) control mice
and PDK1fl/fl Vav Cre+ve (KO) mice. Percentage for each DC population is indicated, as well as the gating strategy (arrows). Data are representative of two
experiments each done with three PDK1fl/fl Vav Cre+ve mice and three PDK1+/+ Vav Cre+ve control mice. cDC, conventional DC; dDC, dermal DC; HF, hair
follicles; pDC, plasmacytoid DC; rDC, resident DC.
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proliferate was affected. We measured the percentage of LC that
were cycling by flow cytometry. In WT mice, between 1 and 2%
of LC were in M/S/G2 phases of the cell cycle (Fig. 3D,
Supplemental Fig. 1C), broadly consistent with earlier studies
(2, 3). In contrast, only 0.5% of LC were cycling in Rsk1/2-null
mice, likely accounting for reduced LC density. The murine LC
network is established during the first week of life by a tran-
sient burst of LC proliferation (3, 4). As shown in Fig. 3E and
3F, on day 5 after birth the density of LC was again substan-
tially reduced in the epidermis of Rsk1/2-null mice compared
with WT mice, showing that Rsk is needed for normal LC
development early in adult life. Numbers of LC and their cell
cycle status were more difficult to assess reliably in 1-d-old
mice because of low numbers of available Rsk1/2-null mice,
some uncertainty as to their exact age because cages were not
continuously monitored to establish time of birth, and few LC
at this stage. Although LC density was apparently reduced in
1-d-old Rsk1/2-null mice, this did not reach significance (Fig.
3F). Similar to the adult epidermis, the shortfall in LC numbers
seen in newborn epidermis was accompanied by a striking
3-fold increase in LC size (Fig. 3F).
Re-establishment of LC in adult mice after inflammation does
not require Rsk
We next asked whether the LC phenotype is cell intrinsic or might
result from the absence of Rsk1/2 in other cell types present in
the epidermis such as DETC and keratinocytes (37). Also, we
wanted to establish whether Rsk1/2 were also required when the
LC network is ablated and then re-established in the adult from
bone marrow precursors. We generated radiation bone marrow
chimeric mice where the recipient background was either WT or
lacked Rsk1/2. UV-induced inflammation of one ear was used to
FIGURE 2. LC are reduced but larger in Rsk1/2-
null mice. (A) Size of Rsk1/2-null mice (KO)
compared with littermate WT control mice. (B)
Immunofluorescence of WT or Rsk1/2-null epider-
mal sheets stained with DAPI (blue) and class II
MHC Abs (green) to detect LC. Scale bars, 100 mm
(left panels); 50 mm (right panels). Right panels
represent a magnification of the indicated region in
the respective left panels. Data are representative of
seven independent experiments. (C) Density (left)
and surface area (right) of LC (class II MHC+ cells)
in WT or RSk1/2-null epidermal sheets (density:
WT, n = 10 mice, KO, n = 7 mice; area: WT, n = 6
mice, KO, n = 6 mice). Individual mice are shown
with the mean. (D) Density of Iba-1+ cells in the
cortex and in the hippocampus (n = 3 mice/group, 4
fields/mouse). Data are expressed as mean of three
biological replicates 6 SEM. (E and F) DC subset
distribution in Rsk1/2-null mice. (E) Flow-cytom-
etry analysis of DC populations in spleen (E) and
skin draining lymph nodes (F) of Rsk1/2-null or wt
control mice. Gating strategy is indicated by arrows.
Data are representative of six wt and six Rsk1/2-null
mice. cDC, conventional DC; dDC, dermal DC; HF,
hair follicles; pDC, plasmacytoid DC; rDC, resident
DC. *p = 0.01–0.05, ***p , 0.001.
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induce the replacement of recipient LC by donor LC (5). Rsk1/2-
null mice reconstituted with WT bone marrow repopulated he-
matopoietic compartments normally (Supplemental Fig. 2). Five
weeks after UV treatment, donor-derived LC were quantified and
their surface area measured. As shown in Fig. 4A, the lack of
Rsk1/2 in keratinocytes and DETC did not alter the size and the
number of repopulating LC relative to WT recipients.
We also made the reciprocal chimera where irradiated WT
recipients were reconstituted with WTor Rsk1/2-null donor cells.
Reconstitution of T cell, B cell, and DC in the spleen was normal
whether donor cells expressed Rsk1/2 (Supplemental Fig. 3), and
UV irradiation resulted in efficient loss of host CD45.1 LC and
replacement by donor CD45.2 LC (Supplemental Fig. 3E).
Moreover, this re-established LC network had similar density
and cell-surface area parameters irrespective of whether WT or
Rsk1/2-null donor cells were used (Fig. 4B). Thus, an apparently
normal LC network can be re-established when Rsk1/2 is absent
either in the recipient background or in donor precursors that
reconstitute LC. This indicates that Rsk1/2 are required for
normal neonatal LC development, but not for re-establishment
of the LC network after an inflammatory insult. This may reflect
the distinct precursor cell types, extracellular cues, and signaling
pathways operating under these different conditions.
LC size increases in Rsk1/2-null mice are reversible and
correlate inversely with LC number
Rsk1/2-null LC were not only fewer but also had increased
surface area or “footprint” compared with WT LC (Figs. 2C, 3F).
FIGURE 3. Loss of epidermal LC is not due
to enhanced migration but to a proliferation
defect. (A) WT or Rsk1/2-null (KO) ear splits
were incubated for 0 (control) or 72 h at 37˚C
in RPMI 1640 medium supplemented with 10%
FCS, non-essential amino acids, Na pyruvate,
kanamycin and beta-mercaptoethanol. Epider-
mal sheets were isolated, fixed, and stained
with MHC class II Abs and analyzed by im-
munofluorescence to measure LC density. Data
are expressed as percentage of LC that have
migrated. Data represent the mean of three
biological replicates 6 SEM and are represen-
tative of two experiments. (B and C) Flow-
cytometry analysis of CD45+ LC in the dermis
(B) and in the skin draining lymph nodes (C) of
WT or KO mice. Dot plots (left) represent one
individual mouse. Histograms show the per-
centage of LC in the dermis [(B) class II MHC+
EpCAM+] and in skin draining lymph nodes
[(C ), DAPI2 CD11cint EpCAM+)]. Data rep-
resent the mean of four (B) or nine (C) biological
replicates 6 SEM. (D) Cell-cycle analysis of
LC (CD45+ EpCAM+) in the epidermis of WT
or KO mice. The percentage of LC in M/S/G2 is
shown. Data represent the mean of five bio-
logical replicates 6 SEM. (E) Immunofluores-
cence of epidermal sheets of 5-d-old WT and
KO newborn mice stained with MHC class II
Abs. Scale bar, 50 mm. Data are representative
of six WT and six KO mice. (F) Quantification
of the number (left) of LC/mm2 (MHC class II+
cells) in 1- or 5-d-old WT or KO epidermal
sheets (1 d old: WT = 8 mice, KO = 5 mice; 5 d
old: WT = 6 mice, KO = 6 mice) and surface
area (right) of 5-d-old WT or KO LC (WT = 6
mice, KO = 4 mice). Individual mice are shown
with the mean. *p = 0.01–0.05, **p = 0.001–
0.01, ***p , 0.001.
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We considered several explanations for this striking phenotype.
First, increased cell size could be the result of a delay in cell-
cycle progression. In other words, Rsk1/2-null LC could be
spending more time in the growth phases G1 and/or G2. Although
this might be the case in neonates where LC are proliferating, it
is unlikely to account for the size difference of LC in adult mice
where only a low percentage of cells are cycling. Second, be-
cause a recent report showed that mTORC1 is important in
regulating the size and numbers of LC (18), we measured the
activity of the mTORC1 activated kinase S6K (33) in WT or
Rsk1/2-null LC by flow cytometry. However, LC had similar
levels of S6 phosphorylation in the presence or in the absence
of Rsk1/2, suggesting that mTORC1 activity is not affected
(Fig. 5A). Third, LC activation is known to be accompanied by
an increase in cell size (8), raising the possibility that Rsk1/2-
null LC might be larger because they have a more activated
phenotype. However, epidermal Rsk1/2-null and WT LC expressed
similar levels of MHC class II and of the costimulatory mole-
cules CD40 and CD86 (Fig. 5B), indicating that increased LC
size is not due to increased maturation of LC in the absence of
Rsk1/2. Finally, we considered the possibility that the increase in
LC footprint might not be directly linked to the absence of Rsk
signaling, but rather was a response triggered by the shortfall in
LC numbers.
To explore this further, we measured LC surface area and
volume in neonatal and adult epidermis from Rsk1/2-null and
WT mice. Interestingly, although 5-d-old Rsk1/2-null mice had
a greater volume as well as greater surface area, in adult Rsk1/
2-null mice, increased surface LC area was not accompanied
by a statistically significant increase in cell volume (Fig. 5C).
This implied that in adult mice, overall differences in cell size
had normalized but Rsk1/2-null LC had undergone a change in
cell shape, which increased their “footprint.” Also, comparing 5-
d-old and adult WT mice, we noted that LC density was lower in
the latter, but surface area was greater, suggestive of a link be-
tween these parameters (Figs. 2C, 3F). We performed two ad-
ditional experiments to test the notion of an intrinsic inverse
relationship between LC density and LC surface area or “foot-
print.” First, using random sampling of areas of epidermis in
multiple WT mice, we measured LC density and LC surface
area. As shown in Fig. 5D, LC density varied over a 2- to 3-fold
range from mouse to mouse, but importantly so did LC surface
area or “footprint,” which correlated inversely. As expected, data
points from the Rsk1/2-null mice had the highest LC surface
area/LC density area ratio (Fig. 5D). Second, we reasoned that if
increased LC size in Rsk1/2-null mice was a tissue-based re-
sponse to reduced cell density, this should normalize after emi-
gration of LC to dermis and then lymph nodes. Indeed, the
greater side-scatter measured by flow cytometry for Rsk1/2-null
LC isolated from epidermis normalized when the same cells
were sampled in dermis and lymph nodes after emigration from
the epidermis (Fig. 5E). Taken together, these results indicate
that LC can increase their surface area when LC density is re-
duced and that the Rsk1/2-null mice illustrate a particularly
striking example of this response. Upon exit from the epidermis,
this apparently compensatory response is normalized.
Discussion
Although some of the key cytokines and specific transcription
factors needed for LC development and homeostasis have re-
cently been revealed (17), the intracellular signaling pathways
that might link the two have only just begun to be investigated.
Our study demonstrates for the first time, to our knowledge,
a role for two members of the AGC kinase family, namely,
PDK1 and its downstream substrates Rsk1 and Rsk2, in the
development and maintenance of the LC network. Because no
LC were observed in PDK1fl/fl/Vav-Cre+ve mice, we reasoned
that one or more of its several downstream effector kinases
might be critical for LC development. Indeed, mice lacking
Rsk1 and Rsk2 had half as many LC in the adult epidermis most
likely because of a defect in LC proliferation. Remarkably, LC
size was strikingly increased in Rsk1/2-null mice. If Rsk1/2 are
activated downstream of PDK1, why do PDK1fl/fl/Vav-Cre+ve
mice lack all LC but Rsk1/2 mice have only reduced numbers?
PDK1 is a constitutively active kinase that regulates .20
downstream target kinases by either PI3K-dependent or -inde-
pendent mechanisms (33). Thus, partial depletion of LC in
Rsk1/2-null mice versus complete lack of LC in PDK1fl/fl/Vav-
Cre+ve mice suggests that additional PDK1 target kinases be-
sides Rsks are also important for LC development. Indeed,
another PDK1 target kinase PKB/Akt is implicated in DC/LC
development in mice and humans because of its key role in the
PI3K/Akt/mTOR signaling pathway (18, 38).
Despite having been implicated in several biological processes,
the study of the Rsk kinases has been hindered by the ubiquitous
expression of at least three of the four isoforms (21). The gen-
eration of single, double, and triple Rsk1, Rsk2, and Rsk3 KO
mice is starting to provide new insights into their roles (29).
Lack of Rsk1, Rsk2, or Rsk3 individually had little impact on LC
development, but ablation of both Rsk1 and Rsk2 selectively
impaired the establishment of LC, but not other DC subtypes. In
Rsk1/2-null epidermis, the fraction of LC in cell cycle was only
one third of that in WT mice, indicating that reduced LC num-
bers in adult mice were due to a proliferation defect. Five-day-
old Rsk1/2-null mice also had significantly fewer LC, but we
could not unequivocally establish that this was due to a defect in
FIGURE 4. LC require Rsk1/2 for neonatal but not adult repopulation.
(A) Irradiated WT or KO recipients (CD45.2) were reconstituted with WT
bone marrow cells (CD45.1) and UV treated. Epidermal sheets were
stained with MHC class II and CD45.2 Abs. Percentage of WT donor-
derived LC (class II MHC+ CD45.22) with or without UV treatment (left)
and their surface area (right) are shown. (B) Irradiated WT recipients
(CD45.2) were reconstituted with either WT or KO bone marrow cells
(CD45.2) and UV treated. Epidermal sheets were stained with MHC class
II and CD45.2 Abs. Percentage of WT or KO donor-derived LC (MHC
class II+ CD45.2+) with or without UV treatment (left) and their surface
area (right) are shown. (A and B) Data are expressed as mean of three
biological replicates 6 SEM.
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the postnatal proliferative burst. For technical reasons, LC numbers
and cell cycle status were more difficult to determine accurately on
day 1 after birth. Numbers appeared lower in Rsk1/2-null mice, but
statistical significance was not obtained. We cannot rule out the
possibility that reduced seeding of the epidermis with relevant LC
precursors might also occur in Rsk1/2-null mice. Although Rsk1/2
signaling was required for establishment and maintenance of the LC
network, it appeared to be dispensable when the network was ab-
lated after an inflammatory insult and restored from bone marrow–
derived cells. This may reflect the distinct precursor cell types,
extracellular cues, and signaling pathways operating under these
different conditions.
Two recent studies have also reported that deficiencies in
signaling pathways linked to cell growth and division perturb
the LC network (18, 19). Deletion in LC of Raptor, a key subunit
of the mTORC1 complex, or p14 (LAMTOR2), an adaptor re-
quired for mTORC1 and Erk1/2 signaling from the endosomal/
lysosomal compartment, resulted in progressive loss of LC in
newborn mice. This was primarily due to enhanced emigration
from the skin in the case of Raptor deficiency (18) and reduced
LC proliferation in neonates in the case of p14 deficiency (19).
In the latter case, reduced levels of TGF-b receptor II render
DC/LC hyporesponsive to TGF-b1 (20), which is critical to
maintain LC. Rsks are directly linked to these signaling path-
ways being both downstream effectors of Erk1/2 signaling and
upstream activators of mTORC1 signaling (21, 39). Indeed, Rsks
can activate mTORC1 by direct phosphorylation of Raptor, as
well as by phosphorylation and inactivation of the mTORC1
inhibitor TSC2. The LC phenotype of Rsk1/2-null mice was,
however, distinct to those with deficiencies in mTOR signal-
ing. We found no evidence for increased LC apoptosis in Rsk-
deficient mice and neither did Rsk-deficient LC migrate faster to
draining lymph nodes. Unlike p14 and Raptor-deficient LC,
Rsk1/2-null adult mice were able to maintain LC but at a strik-
ingly reduced density.
Rsks have been linked to the promotion of cell proliferation
(21), but to our knowledge, only one other study, in Rsk2-
deficient T cells, demonstrates that cell-cycle progression in
vivo is slowed in the absence of Rsk2 (40). Consistent with
a positive role for Rsk in promoting cell cycling, fewer LC were
in cycle in Rsk1/2-null mice. Rsks regulate cell-cycle progres-
sion through various substrates such as p27kip1 (41, 42) and
myt1/cdc2 (43). Analysis of Rsk effectors in LC presents chal-
lenges because of their relatively low abundance and the length
of time required to isolate them. Nonetheless, we could not
detect altered myt1/cdc2 phosphorylation and p27kip levels in
Rsk1/2-null LC. Another Rsk substrate is c-fos, which induces
cyclin D transcription (44). Indeed, c-fos levels were reduced in
Rsk1/2-null LC, but cyclin D levels were not obviously affected
(data not shown). Identification of Rsk substrates in LC and
other DC will be important, as will the investigation of links
between LC growth factor receptors and Rsk. As a potent acti-
FIGURE 5. LC may increase their size to maxi-
mize epidermal surveillance. (A) Flow-cytometry
analysis of S6 phosphorylation and CD40, CD86,
and class II MHC surface expression (B) in WT or
KO LC isolated from the epidermis (A and B).
Histograms represent one individual mouse for each
genotype and are representative of three mice each.
(C) Measurement of LC volume of WT or KO 5-d-
old mice (WT = 6 mice, KO = 4 mice) (left panel)
and of adult mice (WT = 8 mice, KO = 7 mice)
(right panel). Individual mice are shown with the
mean. (D) LC density versus surface area is shown
for 11 WT mice (n = 11) and KO (n = 6) mice. The
Pearson coefficient is shown. (E) Histograms show
the forward scatter analysis by flow cytometry of
LC isolated from the epidermis (CD45+, class II
MHC+), dermis (CD45+, CD11c+, class II MHC+,
EpCAM+), and the skin draining lymph nodes
(CD11c+, class II MHC+, EpCAM+) of WT or KO
mice. Histograms represent one individual mouse
for each genotype and are representative of at least
three mice each. Middle panel shows the FSC for
three independent experiments. Each point is the
mean of two mice/genotype/experiment. *p = 0.01–
0.05, ***p , 0.001.
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vator of Erk1/2 signaling (27), IL-34 activates Rsk (data not
shown), but whether Rsk is a critical effector of IL-34 signaling
remains to be established. Levels of IL-34 and TGF-b mRNA
were actually somewhat increased in the epidermis of Rsk1/2-
mull mice (data not shown), apparently ruling out deficiency of
these key LC-promoting cytokines as an explanation for reduced
LC numbers.
LC in Rsk1/2-null mice were not only fewer in number but
strikingly increased in size. Rsk1/2-null mice LC had a “footprint”
3- or 2-fold greater than that of their WT counterparts in 5-d-old
and adult mice, respectively. The possibility that this was simply
due to cell growth without cell division is ruled out, at least in
adults, because only 2–3% of LC are proliferating. Nor did Rsk1/2
null LC appear to be more activated, which is known to trigger LC
enlargement. Because Rsks are widely reported to promote cell
growth through activation of protein translation via mTORC1
and other pathways (21), LC enlargement in Rsk1/2-null LC
was unexpected. However, Rsks are not the sole activators of
mTORC1 and, based on ribosomal S6 protein phosphorylation
measured directly in LC, the activity of this key growth regulating
kinase appeared unaffected by the absence of Rsks. Consistent
with this, LC volume was essentially the same in Rsk1/2-null and
WT adult epidermis. We suggest that increased LC surface area in
Rsk1/2-null mice is achieved by a morphological change in re-
sponse to reduced LC numbers. In the simplest case, this could be
achieved by a flattening and broadening of the cells footprint
without a substantial volume increase.
Several observations support the notion of an intrinsic inverse
relationship between LC numbers and apparent LC size. First,
LC surface area or footprint also correlated inversely with LC
density in the epidermis of WT mice, indicating a normal be-
havioral feature of LC. Second, Rsk1/2-null bone marrow pre-
cursors were able to repopulate inflamed epidermis to the same
density as WT precursors and showed normal size parameters.
Third, upon exit from the epidermis, Rsk1/2-null LC assumed
a normal size, again consistent with a tissue context-specific
response. Fourth, a re-examination of the data in some earlier
studies reveals an inverse correlation between LC size and
density. Although this was sometimes due to LC activation
triggering both increased LC size and LC exodus (45), in other
cases, such as during post embryonic LC colonization of the
epidermis (46) or repopulation after LC ablation (6), LC appear
larger in underpopulated epidermis. Also, Kuipers et al. (47)
reported that Dicer-deficient LC, although reduced in number,
were ∼30% larger than WT LC, potentially reflecting a similar
response. However, to our knowledge, our study is the first to
explicitly document and measure this phenomenon and to in-
vestigate it in more detail.
Additional studies are needed to test the concept further, but an
increase in LC footprint in response to reduced cell density would
make biological sense because it could help offset potentially
compromised surveillance of the epidermis due to reduced LC
numbers. Although their dendrites appear largely sessile under
resting conditions (6, 8), our results may also suggest that LC
nonetheless sense the proximity of their neighbors and can re-
spond accordingly.
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